175 related articles for article (PubMed ID: 16492679)
1. Specific TP53 mutation pattern in radiation-induced sarcomas.
Gonin-Laurent N; Gibaud A; Huygue M; Lefèvre SH; Le Bras M; Chauveinc L; Sastre-Garau X; Doz F; Lumbroso L; Chevillard S; Malfoy B
Carcinogenesis; 2006 Jun; 27(6):1266-72. PubMed ID: 16492679
[TBL] [Abstract][Full Text] [Related]
2. RB1 and TP53 pathways in radiation-induced sarcomas.
Gonin-Laurent N; Hadj-Hamou NS; Vogt N; Houdayer C; Gauthiers-Villars M; Dehainault C; Sastre-Garau X; Chevillard S; Malfoy B
Oncogene; 2007 Sep; 26(41):6106-12. PubMed ID: 17369843
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the p53 gene in postradiation sarcoma.
Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
[TBL] [Abstract][Full Text] [Related]
5. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
[TBL] [Abstract][Full Text] [Related]
6. Genome instability in secondary solid tumors developing after radiotherapy of bilateral retinoblastoma.
Lefèvre SH; Vogt N; Dutrillaux AM; Chauveinc L; Stoppa-Lyonnet D; Doz F; Desjardins L; Dutrillaux B; Chevillard S; Malfoy B
Oncogene; 2001 Dec; 20(56):8092-9. PubMed ID: 11781822
[TBL] [Abstract][Full Text] [Related]
7. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
[TBL] [Abstract][Full Text] [Related]
8. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas.
Hoogervorst EM; Bruins W; Zwart E; van Oostrom CT; van den Aardweg GJ; Beems RB; van den Berg J; Jacks T; van Steeg H; de Vries A
Cancer Res; 2005 May; 65(9):3610-6. PubMed ID: 15867355
[TBL] [Abstract][Full Text] [Related]
9. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis.
Kemp CJ; Wheldon T; Balmain A
Nat Genet; 1994 Sep; 8(1):66-9. PubMed ID: 7987394
[TBL] [Abstract][Full Text] [Related]
10. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
11. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Petitjean A; Mathe E; Kato S; Ishioka C; Tavtigian SV; Hainaut P; Olivier M
Hum Mutat; 2007 Jun; 28(6):622-9. PubMed ID: 17311302
[TBL] [Abstract][Full Text] [Related]
12. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
13. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
[TBL] [Abstract][Full Text] [Related]
14. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
[TBL] [Abstract][Full Text] [Related]
15. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice.
Lee JM; Abrahamson JL; Kandel R; Donehower LA; Bernstein A
Oncogene; 1994 Dec; 9(12):3731-6. PubMed ID: 7970733
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
18. TP53 overexpression in radiation-induced osteosarcoma of the rabbit mandible.
Buchholz TA; McCabe K; Cobb J; Haroff H; Prestidge BR; Ehler WJ
Radiat Res; 1999 Mar; 151(3):278-82. PubMed ID: 10073665
[TBL] [Abstract][Full Text] [Related]
19. Ethanol and aloe emodin alter the p53 mutational spectrum in ultraviolet radiation-induced murine skin tumors.
Badgwell DB; Walker CM; Baker WT; Strickland FM
Mol Carcinog; 2004 Mar; 39(3):127-38. PubMed ID: 14991742
[TBL] [Abstract][Full Text] [Related]
20. Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons.
McHugh JB; Thomas DG; Herman JM; Ray ME; Baker LH; Adsay NV; Rabah R; Lucas DR
Cancer; 2006 Aug; 107(3):554-62. PubMed ID: 16795069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
